Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2011

Open Access 01-09-2011

Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study

Authors: Linda C. Harlan, Charles F. Lynch, Theresa H. M. Keegan, Ann S. Hamilton, Xiao-Cheng Wu, Ikuko Kato, Michele M. West, Rosemary D. Cress, Stephen M. Schwartz, Ashley W. Smith, Dennis Deapen, Sonja M. Stringer, Arnold L. Potosky, the AYA HOPE Study Collaborative Group

Published in: Journal of Cancer Survivorship | Issue 3/2011

Login to get access

Abstract

Introduction

Cancer is rare in adolescents and young adults (AYA), but these patients have seen little improvement in survival in contrast to most other age groups. Furthermore, participation in research by AYAs is typically low. We conducted a study to examine the feasibility of recruiting a population-based sample of AYA survivors to examine issues of treatment and health outcomes.

Methods

Individuals diagnosed in 2007–08 and age 15–39 at the time of diagnosis with acute lymphocytic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, germ cell cancer or sarcoma were identified by 7 Surveillance, Epidemiology, and End-Results (SEER) cancer registries, mailed surveys within 14 months after diagnosis and again a year later, and had medical records reviewed.

Results

525 (43%) of the eligible patients responded, 39% refused and 17% were lost to follow-up. Extensive efforts were required for most potential respondents (87%). 76% of respondents completed the paper rather than online survey version. In a multivariate model, age, cancer site, education and months from diagnosis to the first mailing of the survey were not associated with participation, although males (p < 0.01), Hispanics and non-Hispanic blacks (p < 0.001) were less likely to participate. 91% of survivors completing the initial survey completed the subsequent survey.

Discussion

Despite the response rate, those who participated adequately reflected the population of AYA cancer survivors. The study demonstrates that cancer registries are valuable foundations for conducting observational, longitudinal population-based research on AYA cancer survivors.

Implications for Cancer Survivors

Achieving a reasonable response rate in this population is possible, but requires extensive resources.
Appendix
Available only for authorised users
Literature
1.
go back to reference Heron MP. Deaths: Leading causes for 2004. National vital statistics reports: vol 56 no 5. Hyattsville, MD: National Center for Health Statistics, 2007. Heron MP. Deaths: Leading causes for 2004. National vital statistics reports: vol 56 no 5. Hyattsville, MD: National Center for Health Statistics, 2007.
2.
go back to reference Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107(7 Suppl):1645–55.PubMedCrossRef Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107(7 Suppl):1645–55.PubMedCrossRef
3.
go back to reference Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescent and young adults with cancer. Pediatr Blood Cancer. 2008;50:1101–04.PubMedCrossRef Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescent and young adults with cancer. Pediatr Blood Cancer. 2008;50:1101–04.PubMedCrossRef
4.
go back to reference Loberiza FR, Cannon AJ, Weisenburger DD, Vose JM, Moehr MJ, Bast MA, et al. Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. J Clin Oncol. 2009;27:5376–82.PubMedCrossRef Loberiza FR, Cannon AJ, Weisenburger DD, Vose JM, Moehr MJ, Bast MA, et al. Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. J Clin Oncol. 2009;27:5376–82.PubMedCrossRef
7.
go back to reference Bellizzi KM, Miller MF, Arora NK, Rowland JH. Positive and negative life changes experienced by survivors of non-Hodgkin’s lymphoma. Ann Behav Med. 2007;34:188–99.PubMedCrossRef Bellizzi KM, Miller MF, Arora NK, Rowland JH. Positive and negative life changes experienced by survivors of non-Hodgkin’s lymphoma. Ann Behav Med. 2007;34:188–99.PubMedCrossRef
8.
go back to reference Richards J, Wiese C, Katon W, Rockhill C, McCarty C, Grossman D, et al. Surveying Adolescents enrolled in a regional health care delivery organization: mail and phone follow-up—What works at what cost? JABFM. 2010;23:534–41.PubMedCrossRef Richards J, Wiese C, Katon W, Rockhill C, McCarty C, Grossman D, et al. Surveying Adolescents enrolled in a regional health care delivery organization: mail and phone follow-up—What works at what cost? JABFM. 2010;23:534–41.PubMedCrossRef
9.
go back to reference Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the childhood cancer survivor study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229–39.PubMedCrossRef Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the childhood cancer survivor study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229–39.PubMedCrossRef
10.
go back to reference Bleyer A, Budd T, Montello M. Older adolescents and young adults with cancer and clinical trials: Lack of participation and progress in North America. In: Bleyer A, Barr R, editors. Cancer in adolescent and young adults. Heidelburg: Springer Verlag; 2007. p. 71–81.CrossRef Bleyer A, Budd T, Montello M. Older adolescents and young adults with cancer and clinical trials: Lack of participation and progress in North America. In: Bleyer A, Barr R, editors. Cancer in adolescent and young adults. Heidelburg: Springer Verlag; 2007. p. 71–81.CrossRef
11.
go back to reference Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2008;15:1818–9.CrossRef Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2008;15:1818–9.CrossRef
13.
go back to reference Beebe TJ, Talley NJ, Camilleri M, Jankins SM, Anderson KJ, Locke GR. The HIPAA authorization form and effects on survey response rates, non-response bias, and data quality: a randomized community study. Med Care. 2007;45:959–65.PubMedCrossRef Beebe TJ, Talley NJ, Camilleri M, Jankins SM, Anderson KJ, Locke GR. The HIPAA authorization form and effects on survey response rates, non-response bias, and data quality: a randomized community study. Med Care. 2007;45:959–65.PubMedCrossRef
14.
go back to reference Nelson K, Elena Garcia R, Brown J, Mangione CM, Louis TA, Keller E, et al. Do patient consent procedures affect participation rates in health services research? Med Care. 2002;40:283–8.PubMedCrossRef Nelson K, Elena Garcia R, Brown J, Mangione CM, Louis TA, Keller E, et al. Do patient consent procedures affect participation rates in health services research? Med Care. 2002;40:283–8.PubMedCrossRef
15.
go back to reference Lenhart A, Purcell K, Smith A, Zickuhr K. Social media & mobile Internet use among teens and young adults. In Pew Internet & American Life Project. Pew Research Center: Washington, DC; 2010. Lenhart A, Purcell K, Smith A, Zickuhr K. Social media & mobile Internet use among teens and young adults. In Pew Internet & American Life Project. Pew Research Center: Washington, DC; 2010.
16.
go back to reference Ziegenfuss JU, Beebe TJ, Rey E, Schleck C, Locke GR, Talley NJ. Internet option in a mail survey: more harm than Good? Epidemiology. 2010;21:585–86.PubMedCrossRef Ziegenfuss JU, Beebe TJ, Rey E, Schleck C, Locke GR, Talley NJ. Internet option in a mail survey: more harm than Good? Epidemiology. 2010;21:585–86.PubMedCrossRef
Metadata
Title
Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study
Authors
Linda C. Harlan
Charles F. Lynch
Theresa H. M. Keegan
Ann S. Hamilton
Xiao-Cheng Wu
Ikuko Kato
Michele M. West
Rosemary D. Cress
Stephen M. Schwartz
Ashley W. Smith
Dennis Deapen
Sonja M. Stringer
Arnold L. Potosky
the AYA HOPE Study Collaborative Group
Publication date
01-09-2011
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2011
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-011-0173-y

Other articles of this Issue 3/2011

Journal of Cancer Survivorship 3/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine